The 3 Most Profitable Marijuana Stocks You Can Buy Right Now

In 2019, the vast majority of licensed cannabis producers have been losing money at a time when investors were expecting the profits to start rolling in. Among those with at least $20 million in annual sales, all but a handful reported losses in the most recent quarter.

The Public Cannabis Company Revenue Tracker at New Cannabis Ventures currently lists just seven companies in North America with operations that squeaked out a profit during their most recent quarter. Here’s how the top three performers have been able to make money while their peers report accelerating losses.

Company (Symbol) Market Cap Adjusted Operating Income Quarter Ended
Trulieve (NASDAQOTH:TCNNF) $1.1 billion $16.5 million 03/31/19
Organigram (NASDAQ:OGI) $952 million $4.8 million 02/28/19
Innovative Industrial Properties (NYSE:IIPR) $1.3 billion $3.4 million 03/31/19


1. Trulieve: Well positioned

After excluding fair value changes that cannabis growers are required to report, Trulieve’s operations produced a $16.5 million profit. That made it the most profitable cannabis producer on the continent.

Trulieve holds an enviable position in Florida’s burgeoning market for medical marijuana, thanks to its headquarters near the state capital and 14 dispensaries grandfathered in before the state decided to limit retail locations to 25 per operator. At the end of May, Trulieve operated 28 of the state’s 123 open dispensaries, and Trulieve can go all the way up to 44.

The state of Florida offers much wider profit margins than many states with older programs, because dispensary operators can only sell products that they cultivate and process in their own state-licensed facilities.

Although Trulieve has been the most profitable cannabis producer around, it may have trouble holding the title in 2020 and beyond. Unsatisfied with profits from its Florida-based businesses, Trulieve has been buying up assets in Massachusetts, California, and Connecticut that could struggle to provide a return.

2. Organigram: Canada’s finest

This company is proof that licensed Canadian producers can make money if they’re careful. Organigram reported earnings before interest, taxes, depreciation, and amortization (EBITDA) that reached an impressive 49% of net revenue in the first quarter.

Organigram reported net revenue that soared 117% over the previous quarter. Over the same time frame spending on sales, general, and administrative expenses rose just 27% to CA$5.7 million.

Organigram was the only Canadian cannabis producer with significant revenue that churned out a profit during its most recently reported quarter. Although it has all of its peers beat, the stock’s been trading at 23.7 times trailing sales, which is awfully high for most consumer goods companies with commoditized products.

Licensed cannabis inventories in Canada have been rising, leading investors to fear possible inventory writedowns in the near future. While its peers have trouble producing products that Canadians actually want to buy, Organigram is moving its products through the supply chain without much trouble at all. According to Health Canada, inventories of cannabis oil reached 119,696 liters in April, which would last around 14 months at the country’s current consumption rate. Organigram’s oil inventory actually fell during the three months ended February, to 6,246 liters after the company sold 5,735 liters during the period…

Continue reading at THE MOTLEY FOOL


Leave a Reply

Your email address will not be published. Required fields are marked *